Sinovac Biotech Ltd (SVA) SEC filings

Sinovac Biotech Ltd (SVA) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported SVA revenue for 2025-12-31 was $386.0M. Net income was -$198.8M. Revenue was up 6.8% from 2024-12-31 to 2025-12-31. SVA currently screens at market cap $642.4M. The SVA filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Sinovac Biotech Ltd said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.